Let's look at two companies that fit the bill: Amgen (NASDAQ: AMGN) and Microsoft (NASDAQ: MSFT). Biotech Amgen has been around since 1980, and in that time the company has survived several recessions. In the first quarter, Amgen's revenue increased by a respectable 6% year over year to $6.2 billion. Read More...
Let’s look at two companies that fit the bill: Amgen (NASDAQ: AMGN) and Microsoft (NASDAQ: MSFT). Biotech Amgen has been around since 1980, and in that time the company has survived several recessions. In the first quarter, Amgen’s revenue increased by a respectable 6% year over year to $6.2 billion.
Add Comment